In response to the growing demand for high-quality packaging solutions for the medical sector, the Coveris Group is investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany.
As a leading packaging manufacturer, Coveris is investing more than eight million euros in the coming months to upgrade and expand its medical device production lines.
Meeting highest medical packaging requirements
The state-of-the-art facility in Rohrdorf has been in operation since May 2021 and meets the highest medical packaging production requirements and standards including ISO Class 7 certification. Two new pouch lines and one headerbag line will be installed in autumn 2024 to deliver an even better service level and meet growing market demands. The new pouch and bag lines are technologically similar to the site’s existing capabilities, assuring fast and seamless integration into the machine park. In parallel, a new cast extrusion line will be installed at the company’s sister medical site in Halle to further support the growth of Coveris’s medical packaging capacity.
In Rohrdorf, all three new lines will be in operation by 1 October 2024, and the first commercial production in Halle using the new extrusion line is expected at the start of 2025.
Further strengthening the medical segment
“We are investing in site upgrades to further strengthen our medical segment and continue answering growing customer needs for high performance medical packaging. A clean and safe production environment is extremely important for this sector, but sustainability is also key. The new cast line supports the development of innovative monomaterial-based, recyclable and sustainable flexible packaging solutions for the medical industry. Additionally, both facilities are functioning with our No Waste strategy in mind, operating on electricity from renewable resources,” summarised Christian Kolarik, CEO of Coveris, about the investments.